Alvesco® Glucocorticosteroid for topical application Aerosol for inhalation dosage 40 μg / spray, 80 μg / spray, 160 μg / spray. Atacand® Angiotensin II receptor antagonist Tablets of 8 and 16 mg. Atacand® Angiotensin II receptor antagonist Tablets of 32 mg. Atacand® Plus Hypotensive combined agent (angiotensin II receptor blocker + diuretic) Pills 16 mg + 12.5 mg. Betaloc® Beta1-blocker selective Tabletki, 100 mg. Betaloc® Beta1-blocker selective Solution for intravenous administration, 1 mg / ml. Betalok® ZOK Beta1-blocker selective Tablets with delayed release, coated with a coating, 25 mg, 50 mg and 100 mg. Brilinta® Antiaggregant agent Film-coated tablets, 90 mg. Brilinta® Antiaggregant agent The tablets covered with a film membrane, 60 mg. Daxas Anti-inflammatory agent - phosphodiesterase 4 (PDE4) inhibitor Film coated tablets 0.5 mg. Logimax® A combined hypotensive drug (beta-blocker + BCCC) Tablets of prolonged action, film-coated, 50 mg + 5 mg. Losek® MAPS® glands of the stomach secretion-lowering agent - proton pump inhibitor Tablets, film-coated 10 mg or 20 mg. Marcain Spinal local anesthetic Solution for injection 5 mg / ml. Markain Spinal Heavy local anesthetic Solution for injection 5 mg / ml. Nexium® glands of the stomach secretion-lowering agent - proton pump inhibitor Tablets coated with a coating, 20 mg and 40 mg. Nexium® glands of the stomach secretion-lowering agent - proton pump inhibitor Lyophilizate for the preparation of a solution for intravenous administration of 40 mg. Nexium® a means of reducing the secretion of the glands of the stomach - the proton pump inhibitor Pellets, coated with an enteric coating, and granules for the preparation of a suspension for oral administration, 10 mg Nexium® a means of reducing the secretion of the glands of the stomach - the proton pump inhibitor Pellets, coated with enteric coating, and granules for the preparation of a suspension for oral administration, 10 mg. Oxus® Turbuhaler® Bronchodilator-beta2-adrenergic selective The powder for inhalation is dosed at 4.5 μg / dose and 9 μg / dose. Pulmicort® Glucocorticosteroid for topical application. Suspension for inhalations dosed with 0.25 mg / ml and 0.5 mg / ml. Pulmicort® Turbuhaler® glucocorticosteroid for topical application Powder for inhalation dosed with 100 μg / dose, 200 μg / dose. Symbicort® Turbuhaler® bronchodilating agent combined (beta2-adrenomimetic selective + glucocorticosteroid local) Powder for inhalation dosed 80 / 4.5 μg / dose and 160 / 4.5 μg / dose. Symbicort® Turbuhaler® Bronchodilator combined (beta2-adrenomimetic selective + glucocorticosteroid local) Powder for inhalation dosed 320 + 9 microgram / dose. Tagrisso Antitumor agent, protein kinase inhibitor Pills, film-coated, 40 mg, 80 mg. Fazlodex ® Antitumor agent, antiestrogen. Solution for intramuscular injection 250 mg / 5 ml. 5 ml into a glass syringe with a safe injection system. Emla® Local anesthetic Cream for local and external use (aluminum tubes) for 5 g and 30 g. Emla® Local anesthetic Therapeutic system.